About this event

American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting — Event Research & Buyer Fit Description

Event at a Glance (Verified from Official Website)

• Event name: AAAAI Annual Meeting
• Organizer: American Academy of Allergy, Asthma & Immunology (AAAAI)
• Main meeting dates (2027): February 19–22, 2027
• City/Region: New Orleans, Louisiana (LA), USA
• Discovery program (2027): February 18–20, 2027
• Location note: The official page states the convention center is centrally located in New Orleans, LA, but it does not provide the convention center name in the provided text.
• Event positioning (2027 theme): “Igniting Transformation Through Research, Technology and Advocacy.”
• Discovery 2027 topic: “Mechanisms of Type 2 Immunity”
• Abstract submission timing (as shown on the page): Abstract Submission Deadline: August 27 (year not explicitly labeled in the provided excerpt, but it appears within the 2026 “Important Dates” section on the page).

This event is best understood as a high-authority allergy / immunology scientific + clinical community meeting that blends research presentations (including plenary/keynote content), advanced scientific tracks (Discovery), and an ecosystem of industry engagement (through exhibitor/sponsor participation and sessions). The AAAAI Annual Meeting is an ideal venue for organizations that want access to allergy & immunology decision-makers, specialty clinicians, academic leaders, and translational research influencers.

1️⃣ Who Attends (BUYERS / ATTENDEES)

The official page emphasizes global connection with “allergy / immunology experts from across the world” and highlights transformative education, cutting-edge research, and connectivity among experts. While the provided text does not list attendee demographics in detail, the meeting’s structure (plenary/keynote/interactive/poster sessions) and the parallel Discovery conference (basic science focus) strongly indicate that attendance is dominated by specialty stakeholders.

Primary attendee clusters (buy-side presence within the ecosystem)

• Allergy & immunology clinicians: specialists who evaluate diagnostics and therapeutics and influence treatment standards.
• Academic researchers and faculty: investigators presenting data and shaping the translational research direction.
• Translational science and basic science researchers (Discovery track): attendees focused on mechanisms of Type 2 immunity and related pathways.
• Health policy and advocacy stakeholders: the official theme explicitly includes advocacy, implying engagement from policy-forward participants and patient-support organizations.
• Industry partners (exhibitors/sponsors): the site includes dedicated exhibitor/sponsor navigation sections (registration and housing alerts), indicating measurable industry presence.
• Press/media: a dedicated “Press Registration & Housing Alert!” and media policies are listed on the page, signaling that some industry participants and researchers may engage for visibility.

In buyer-language (for the purpose of attendee-list targeting research), the “buyers” typically cluster around: pharma/biotech commercial and medical leadership, diagnostics and med-tech business development teams, medical affairs / scientific communications teams, and health technology / research support organizations that need structured access to allergy & immunology leadership.

2️⃣ Where the Show Is Happening + Attendee Geographic Origin

Where the event is happening

• City: New Orleans, LA, USA
• Main meeting dates: February 19–22, 2027
• Discovery dates: February 18–20, 2027
• Venue name: Not specified in the provided excerpt (the page mentions the convention center is centrally located but does not name it).

Attendee geographic origin (inferred directly from official wording)

The page states that attendees include experts “from across the world.” That indicates a global and international mix—even if the meeting is physically hosted in the USA. The meeting’s role as a major AAAAI academic and clinical platform suggests that the largest share is likely domestic U.S. participation with meaningful international representation.

Best geographic targeting (practical segmentation)

• Primary: United States (allergy/immunology specialists, academic faculty, major pharma/biotech operating in the U.S.)
• Strong secondary: Canada and Western Europe (commonly represented in U.S.-hosted medical congresses)
• Additional reach: Global research groups and clinical leaders (implied by “across the world” language)

3️⃣ Audience Reach (Local / National / Global)

Based on the official statement about welcoming allergy/immunology experts “from across the world,” the audience reach is best categorized as global with a strong U.S. core. The meeting theme and the presence of a dedicated basic-science track (Discovery) also point to broader international interest from researchers and translational scientists.

• Reach classification: Global (international) with U.S. dominance
• Why: “Across the world” language + expert community scale + academic/research content depth

4️⃣ Sample Buyer Company Names (BUYERS ONLY) + Websites

Below is a buyer-oriented sample list of organizations that typically participate in allergy/immunology ecosystems via therapeutics, biologics, diagnostics, and medical technology. These samples are presented as “buyer-fit candidates” for AAAAI-style events and should be validated against actual exhibitor/sponsor participation for the specific year if needed.

Top buyer-fit samples to prioritize first (from the table): Genentech, Regeneron, Novartis, Sanofi, and Thermo Fisher Scientific. These provide a strong spread across biologics/medical affairs and research tools, matching both the Annual Meeting and Discovery emphasis.

5️⃣ Job Profiles, Industries & Event Type

Event type (based on official page content)

• Medical specialty congress: Allergy & Immunology
• Research and clinical translation platform: plenary/keynote/interactive/poster sessions
• Basic science track: Discovery 2027 (Mechanisms of Type 2 Immunity)
• Technology and advocacy theme: explicitly stated (“Research, Technology and Advocacy”)

Job profiles to target in an attendee list (buyer-side roles)

• Medical Affairs leadership: Medical Director, Senior Medical Science Liaison, Global/Regional Medical Affairs (Immunology/Allergy)
• Scientific/Clinical strategy: Translational Science Lead, Clinical Strategy Lead, Scientific Programs Manager
• Market access & evidence: HEOR lead, Market Access Director, Evidence Generation Manager
• Diagnostics and research tools business roles: Scientific Sales Director, Segment Manager (Immunology/Lab), Diagnostics Business Development
• Technology platform roles: Life Science Solutions Director, Clinical Platform Sales Lead
• Partnerships and advocacy: Partnerships Director, Patient Engagement/Advocacy Program Lead

Industries to use (from provided Apollo-style industry list)

Since we want the closest match to an allergy/immunology medical and research ecosystem, the best industry filters (from the list provided) typically include:

• Hospital & Health Care
• Pharmaceuticals
• Medical Devices
• Biotechnology
• Research
• Health, Wellness & Fitness (secondary/adjacent where applicable)
• Information Technology & Services (for health tech/clinical platforms; secondary)
• Market Research (for HEOR/outcomes/data organizations; secondary)
• Professional Training & Coaching (only where medical education content firms exist; secondary)

6️⃣ Estimated Attendance (Expected Total Footfall)

Estimated attendance: The provided official excerpt does not state the expected total number of attendees/footfall for the AAAAI Annual Meeting (2027) or for the Discovery track. We should mark this as not provided in the supplied text unless additional official sources are added.

7️⃣ Key Focus Areas & Buyer Engagement

Key focus areas (directly tied to the official page)

• Research transformation: “Igniting Transformation Through Research” (explicit)
• Technology in clinical and research settings: “Through…Technology” (explicit)
• Advocacy: “Through…Advocacy” (explicit)
• Type 2 immunity mechanisms (Discovery): Discovery 2027 is dedicated to mechanisms of Type 2 immunity
• Education formats: plenary, keynote, interactive, and poster sessions (explicit page sections)

How buyers typically engage (what the audience is likely looking for)

• Evidence and mechanistic depth: data-driven updates across allergy and immunologic pathways.
• Clinical translation and patient outcomes: the value of diagnostics, biomarkers, and therapeutic impact.
• Technology enablement: tools that support research pipelines and clinical practice improvements.
• Professional networking: structured conversations between industry medical/scientific leaders and allergy/immunology experts.

8️⃣ Client-product fit: Identifying the best buyer organizations (requires client website)

To recommend the best-fit buyer organizations for this event based on the client’s exact needs, We need the client product details and the client website. The official AAAAI Annual Meeting buyer relevance shifts depending on whether the client sells: therapeutics/biologics, diagnostics, research tools, health technology platforms, clinical services, or education/advocacy programs.

What We need from the client

• Client website URL
• Product category (diagnostics / medical device / pharma/biotech / research tools / software platform / services)
• Target customer type (hospital systems, physician practices, academic research labs, pharma/biotech sponsors, etc.)
• Geography focus (U.S. only vs international)

What We will return after reviewing the client website

• A prioritized list of buyer segments most aligned to AAAAI Annual Meeting attendees
• Recommended job titles to target within those segments
• Suggested industries from the provided industry list for Apollo-style filtering
• An event-ready “best buyers” shortlist (company-level) for list building

Please share the client website so We can map the product to the most relevant buyer set for the AAAAI Annual Meeting / Discovery track.

9️⃣ Final Recommendation (Event Suitability for Buyer/Attendee Research)

The AAAAI Annual Meeting (Feb 19–22, 2027 in New Orleans, LA) plus the Discovery track (Feb 18–20, 2027) is a strong, high-intent event for organizations tied to: allergy and immunology therapeutics, diagnostics and biomarkers, research tools for Type 2 immunity, and health technology and advocacy.

• Best fit buyer categories: pharma/biotech medical affairs leadership, diagnostics and lab technology providers, research tools and translational research support, health tech platforms, and advocacy/partnership organizations.
• Audience reach: Global (with a U.S. core), consistent with the official “across the world” language.
• Best attendee-list targeting strategy: focus on job functions that connect research/clinical evidence to product adoption and partnerships.
• Data gap: expected attendance number is not included in the provided excerpt; it should be verified using additional official sources if required.

Ready for Next Step

Share the client website and a one-line description of the product category, and We will produce: (1) the exact buyer segment list most likely to convert at AAAAI, and (2) an optimized job-title targeting plan aligned to the event’s research + clinical + technology + advocacy focus.